"The ETH Whale" has added approximately $45.4 million to their long ETH position, with the total position size increasing to $203 million.
BlockBeats News, March 19th, according to Coinbob Popular Address Tracker, last night and this morning, the Matrixport affiliated address "ETH Whale Master" (0xa5b0...) continued to long at the price range of 2239 to 2300 US dollars after the ETH price fell to $2300, successively rolling over and adding 20,000 ETH long positions, worth approximately $45.4 million.
After this operation, the total value of its ETH long positions has risen to $153 million, and the average position price has increased from $2043 to $2148. The position has a floating profit of approximately $3.5 million, with a return rate of 34%, and a liquidation price set at $1740.
In addition, it still holds a 20x leveraged BTC long position, with a scale of approximately $49.8 million, an average price of $68.42k, and the current total account position has risen to $203 million.
This address has received funds from Matrixport multiple times and is now the largest on-chain ETH bull. There is another suspected affiliated address (0x6C8...) also holding nearly $100 million in ETH long positions. They often engage in high-volume trading activities with a trading style of buying the dip with a large volume and scalping during high volatility with a volume of over $100 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
